2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
141
Breast Neoplasms
10
Neoplasm Metastasis
8
Neoplasms
5
Bulbo-Spinal Atrophy, X-Linked
5
Triple Negative Breast Neoplasms
4
Salivary Gland Neoplasms
3
Prostate Adenocarcinoma
2
Osteoporosis
2
Lower Urinary Tract Symptoms
2
Hirsutism
2
Thrombocytosis
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Stage I Prostate Adenocarcinoma
1
Sexual Dysfunction, Physiological
1
Recurrence
1
Primary Myelofibrosis
1
Primary Dysautonomias
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Paget Disease, Extramammary
1
PSA Level Greater Than Two
1
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Non Castrate Metastatic Prostate Cancer
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
Metformin
152
Clomiphene
52
Letrozole
41
Inositol
35
Folic Acid
18
Progesterone
17
Exercise
17
Ethinyl Estradiol
13
Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Contraceptives, Oral
12
cetrorelix
11
Pioglitazone
10
High-Intensity Interval Training
10
Cholecalciferol
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
9
Menotropins
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
follitropin alfa
6
drospirenone
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Polycystic Ovary Syndrome
×
bicalutamide
×
Clear all
NCT05647356
2022-12-12
REFUEL PCOS
Royal College of Surgeons, Ireland
Phase NA
Unknown
16 enrolled